James Simon, M.D., clinical professor of obstetrics and gynecology, was mentioned in an article in Healio's Endocrine Today on his study finding Flibanserin, a serotonin receptor 1A agonist/serotonin receptor 2A antagonist, safely and effectively improved the sexual interactions of naturally postmenopausal women diagnosed with hypoactive sexual desire disorder.
Healio - Serotonin Receptor Shows Promise in Hypoactive Sexual Desire Disorder
Latest News
A new research study led by Pedro Gazzinelli Guimaraes, PhD, assistant professor of microbiology, immunology, and tropical medicine, titled “Unraveling the Hidden Regulator: Deciphering Endogenous Retroelement Control of Allergic Type 2 Immune Response,” seeks to understand how dormant viruses in…
George Washington University (GW) School of Medicine and Health Sciences faculty members Andrea A. Anderson, MD, MEd ’23, and Wanda K. Nicholson, MD, MPH, MBA, along with GW Law Dean and Harold H. Green Professor of Law Dayna Bowen Matthew, JD, PhD, were among the 90 regular members and 10…
The George Washington University’s 8th Annual Cardiovascular Symposium, organized by the GW Heart & Vascular Institute, took place on Saturday, Nov. 1, 2025 at the American College of Cardiology Heart House in Washington, DC.